Synthesis and crystal structure of binuclear copper(II) complex bridged by N-(2-Hydroxyphenyl)-N′-[3-(diethylamino)propyl]oxamide: In vitro anticancer activity and reactivity toward DNA and protein

Journal of Biochemical and Molecular Toxicology

Volumn 27, Issue 8, 2013, Pages 412-424

  Gao, Yang ^a   Li, Yan Tuan ^a   Wu, Zhi Yong ^a   Yan, Cui Wei ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

oxamidato bridge; Bicopper(II) complex; Crystal structure; DNA and BSA binding; In vitro anticancer activity

Indexed keywords

AMINO ACID DERIVATIVE; ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; CISPLATIN; CUPRIC ION; DNA; LIGAND; PROTEIN; TRYPTOPHAN;

ABSORPTION SPECTROSCOPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONDUCTANCE; CONFORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA BINDING; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROCHEMISTRY; ELECTRONICS; FLUORESCENCE; GEOMETRY; HERRING; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; INFRARED RADIATION; LIGHT ABSORPTION; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; SPERM; TITRIMETRY; VISCOMETRY; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

BOVINAE; CLUPEIDAE;

BICOPPER(II) COMPLEX; CRYSTAL STRUCTURE; DNA AND BSA BINDING; IN VITRO ANTICANCER ACTIVITY; Μ-OXAMIDATO-BRIDGE;

ANIMALS; CATTLE; CELL LINE, TUMOR; COORDINATION COMPLEXES; COPPER; CRYSTALLOGRAPHY, X-RAY; DNA; HUMANS; HYDROGEN BONDING; MOLECULAR STRUCTURE; OXAMIC ACID; SERUM ALBUMIN, BOVINE;

EID: 84881240190     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21504     Document Type: Article

References (53)

1. Chifotides HT, Dunbar KR. Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA. Acc Chem Res 2005;38(2):146-156.
2. Bruijinin PC, Sadler PJ. New trends for metal complexes with anticancer activity. Curr Opin Chem Biol 2008;12(2):197-206.
3. Esposito BP, Najjar R. Interactions of antitumoral platinum-group metallodrugs with albumin. Coord Chem Rev 2002;232(1):137-149.
4. Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep 2003;10:1663-1682.
5. Wong E, Giandomenico CM. Current status of platinum-based antitumor drugs. Chem Rev 1999;99(9):2451-2466.
6. Rosenberg B, Vancamp L, Trosko JE, Mansour VH. Platinum compounds: a new class of potent antitumour agents. Nature 1969;222:385-386.
7. Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 1999;99(9):2467-2498.
8. Pindur U, Haber M, Sattler KJ. Antitumor active drugs as intercalators of deoxyribonucleic acid. J Chem Educ 1993;70:263-272.
9. Navarro M, Cisneros-Fajardo EJ, Sierralta A, Ferández-Mestre M, Silva P, Arrieche D, Marchán E. Design of copper DNA intercalators with leishmanicidal activity. J Biol Inorg Chem 2003;8(4):401-408.
10. Xu H, Zheng KC, Deng H, Lin LJ, Zhang QL, Ji LN. Effects of the ancillary ligands of polypyridyl ruthenium(II) complexes on the DNA-binding behaviors. New J Chem 2003; 27(8):1255-1263.
11. Xue F, Xie CZ, Zhang YW, Qiao Z, Qiao Z, Xu JY, Yan SP. Two new dicopper(II) complexes with oxamido-bridged ligand: synthesis, crystal structures, DNA binding/cleavage and BSA binding activity. J Inorg Biochem 2012;115:78-86.
12. Rao R, Patra AK, Chetana PR. Synthesis, structure, DNA binding and oxidative cleavage activity of ternary (l-leucine/isoleucine) copper(II) complexes of heterocyclic bases. Polyhedron 2008;27(5):1343-1352.
13. Uma V, Kanthimathi M, Weyhermuller T, Nair BU. Oxidative DNA cleavage mediated by a new copper(II) terpyridine complex: Crystal structure and DNA binding studies. J Inorg Biochem 2005;99(12):2299-2307.
14. Efthimiadou EK, Katsaros N, Karaliota A, Psomas G. Mononuclear copper(II) complexes with quinolones and nitrogen-donor heterocyclic ligands: Synthesis, characterization, biological activity and interaction with DNA. Inorganica Chim Acta 2007;360(15):4093-4102.
15. Sengottuvelan N, Saravanakumar D, Kandaswamy M. Electrochemical, magnetic, catalytic and DNA cleavage studies of binuclear copper(II) complexes derived from pendant substituted tetraaza macrobicyclic compartmental ligands. Polyhedron 2007;26(14):3825-3832.
16. Ruiz R, Faus J, Lloret F, Julve M, Journaux Y. Coordination chemistry of N, N′-bis(coordinating group substituted)oxamides: a rational design of nuclearity tailored polynuclear complexes. Coord Chem Rev 1999;193:1069-1117.
17. Jiang M, Li YT, Wu ZY, Liu ZQ, Wu X. Synthesis, structure and DNA binding properties of [Cu2(heae)(SCN)2]n·nH2O: The first one-dimensional polymeric copper(II) complex bridged alternately by oxamidate and double end-to-end thiocyanate ligands. J Inorg Organomet Polym Mater 2008;18(4):448-456.
18. Li XW, Yu Y, Li YT, Wu ZY, Yan CW. Synthesis, structure, cytotoxic activities and DNA- binding properties of tetracopper(II) complexes with dissymmetrical N, N′-bis(substituted)- oxamides as ligands. Inorganica Chim Acta 2011;367(1):64-72.
19. Lu HH, Li YT, Wu ZY, Zheng K, Yan CW. Synthesis, structure, and DNA-binding studies of a dicopper(II) complex with N-phenolato-N′-[2-(dimethylamino)ethyl]oxamide as ligand. J Coord Chem 2011;64(8):1360-1374.
20. Li XW, Zheng YJ, Li YT, Wu ZY, Yan CW. Synthesis and structure of new bicopper(II) complexes bridged by N-(2-aminopropyl)-N′-(2-oxidophenyl)oxamide: The effects of terminal ligands on structures, anticancer activities and DNA-binding properties. Eur J Med Chem 2011;46(9):3851-3857.
21. Sheldrick GM. SHELXL-97, Program for crystal structure refinement. Germany: University of Gottingen; 1997.
22. Marmur J. A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J Mol Biol 1961;3(2):208-218.
23. Reichmann ME, Rice SA, Thomas CA, Doty P. A further examination of the molecular weight and size of desoxypentose nucleic acid. J Am Chem Soc 1954;76(11):3047-3053.
24. Barton JK, Goldberg JM, Kumar CV, Turro NJ. Binding modes and base specificity of tris(phenanthroline)ruthenium(II) enantiomers with nucleic acids: tuning the stereoselectivity. J Am Chem Soc 1986;108(8):2081-2088.
25. Chaires JB, Dattagupta N, Crothers DM. Studies on the interaction of anthracycline antibiotics and deoxyribonucleic acid: geometry of intercalation of iremycin and daunomycin. Biochemistry 1982;21(17):3933-3940.
26. Cohen G, Eisenberg H. Viscosity and sedimentation study of sonicated DNA-proflavine complexes. Biopolymers 1969;8(1):45-55.
27. Quiming NS, Vergel RB, Nicolas MG, Villanueva JA. Interaction of bovine serum albumin and metallothionein. J Health Sci 2005;51:8-15.
28. Geary WJ. The use of conductivity measurements in organic solvents for the characterisation of coordination compounds. Coord Chem Rev 1971;7(1):81-122.
29. Nakamoto K. Infrared and raman spectra of inorganic and coordination compounds, 5th edition. New York: Wiley; 1997.
30. Ojima H, Nonoyama K. Copper(II) complexes with N, N′-bis(alkylaminoalkyl)oxamides and related ligands. Coord Chem Rev 1988;92:85-111.
31. Li YT, Yan CW, Guan HS. Synthesis and magnetic studies of oxalato-bridged copper(II)- chromium(III)-copper(II) and copper(II)-iron(III)-copper(II) heterotrinuclear complexes. Polyhedron 2003;22:3223-3230.
32. Camurlu P, Yilmaz A, Tatar L, Kisakürek D, Ülkü D. Synthesis, crystal structure and characterization of new transition metal compounds of bromophenols: bis(2, 4, 6-tribromo- phenolato)di(N-methylimidazole)M(II) (M = Co, Cu). Cryst Res Technol 2005;40(3):271-276.
33. Addison AW, Rao TN, Reedijk J, Van Rijin J, Verschoor GC. Synthesis, structure and spectroscopic properties of copper(II) compounds containing nitrogen-sulphur donor ligands; the crystal and molecular structure of aqua[1, 7-bis(N-methylbenzimidazol-2-yl)-2, 6-dithia-heptane]copper(II) perchlorate. J Chem Soc, Dalton Trans 1984;1349-1356.
34. Cremer D, Pople JA. General definition of ring puckering coordinates. J Am Chem Soc 1975;97(6):1354-1358.
35. Jubert C, Mohamadou A, Gérard C, Brandes S, Tabard A, Barbier JP. Equilibrium and structural studies of complexes with a hexadentate ligand containing amide, amine and pyridyl nitrogen donors. Crystal structures of copper(II), nickel(II) and cobalt(III) complexes. J Chem Soc, Dalton Trans 2002;13:2660-2669.
36. Barton JK, Danishefsky AT, Goldberg JM. Tris(phenanthroline)ruthenium(II): stereoselectivity in binding to DNA. J Am Chem Soc 1984;106(7):2172-2176.
37. Pyle AM, Rehmann JP, Meshoyrer R, Kumar CV, Turro NJ, Barton JK. Mixed-ligand complexes of ruthenium(II): factors governing binding to DNA. J Am Chem Soc 1989; 111(8):3051-3058.
38. Lepecq JB, Paoletti C. A fluorescent complex between ethidium bromide and nucleic acids: physical-chemical characterization. J Mol Biol 1967;27(1):87-106.
39. Wang LD, Zheng K, Li YT, Wu ZY, Yan CW. Synthesis and crystal structure of a new copper(II) complex with N, N′-(4, 4′-bithiazole-2, 2′-diyl)diacetimidamide as ligand: Molecular docking, DNA-binding and cytotoxicity activity studies. J Mol Struct 2013;1037:15-22.
40. Nie JJ, Li YT, Li XW, Wu ZY, Yan CW. Synthesis, structure and DNA-binding studies of tetranuclear copper(II) complexes bridged by asymmetrical N, N′-bis(substituted)oxamides. Trans Met Chem 2011;36:341-352.
41. Indumathy R, Radhika S, Kanthimathi M, Weyhermuller T, Nair BU. Cobalt complexes of terpyridine ligand: crystal structure and photocleavage of DNA. J Inorg Biochem 2007; 101(3):434-443.
42. Stern O, Volmer M. The extinction period of fluorescence. Phys Z 1919;20:183-188.
43. Song YM, Yang PJ, Yang ML, Kang JW, Qin SQ, Lü BQ. Spectroscopic and voltammetric studies of the cobalt (II) complex of morin bound to calf thymus DNA. Trans Met Chem 2003;28(6):712-716.
44. Carter MT, Rodriguez M, Bard AJ. Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt(III) and iron(II) with 1, 10-phenanthroline and 2, 2′-bipyridine. J Am Chem Soc 1989;111(24):8901-8911.
45. Satyanarayana S, Dabrowiak JC, Chaires JB. Neither delta-nor lambda-tris(phenanthroline) ruthenium (II) binds to DNA by classical intercalation. Biochemistry 1992;31:9319-9324.
46. Jiang M, Li YT, Wu ZY, Liu ZQ, Yan CW. Synthesis, crystal structure, cytotoxic activities and DNA-binding properties of new binuclear copper(II) complexes bridged by N, N′-bis(N- hydroxyethylaminoethyl)oxamide. J Inorg Biochem 2009;103(5):833-844.
47. Song YL, Li YT, Wu ZY. Synthesis, crystal structure, antibacterial assay and DNA binding activity of new binuclear Cu(II) complexes with bridging oxamidate. J Inorg Biochem 2008;102(9):1691-1699.
48. Hu YJ, Liu Y, Wang JB, Xiao XH, Qu SS. Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin. J Pharm Biomed Anal 2004;36(4):915-919.
49. Peters T. Serum Albumin. Adv Protein Chem 1985;37:161-245.
50. 2± and bovine serum albumin by spectroscopic methods. Biol Trace Elem Res 2008;121:276-287.
51. Bhat SS, Kumbhar AA, Heptullah H, Khan AA, Gobre VV, Gejji SP, Puranik VG. Synthesis, electronic structure, DNA and protein binding, DNA cleavage, and anticancer activity of fluorophore-labeled copper(II) complexes. Inorg Chem 2011;50(2):545-558.
52. Kandagal PB, Ashoka S, Seetharamappa J, Vani V, Shaikh SMT. Study of the interaction between doxepin and human serum albumin by spectroscopic methods. J Photochem Photobiol A Chem 2006;179:161-166.
53. Zhang WJ, Wang F, Li YT, Wu ZY. Synthesis, characterization, and biological properties of N-phenolato-N′-(3-dimethylaminopropyl)oxamide and its binuclear copper(II) complexes. Trans Met Chem 2013;38(1):69-78.